Get started
Author

Noeris K. Salam

Novel Method for Generating Structure-Based Pharmacophores Using Energetic Analysis
2009 · Noeris K. Salam, Roberto Nuti, et al. · Journal of Chemical Information and Modeling · 321
Synthesis, Activity, and Pharmacophore Development for Isatin-β-thiosemicarbazones with Selective Activity toward Multidrug-Resistant Cells
2009 · Matthew D. Hall, Noeris K. Salam, et al. · Journal of Medicinal Chemistry · 168
Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation
2009 · Kathryn Loving, Noeris K. Salam, et al. · Journal of Computer-Aided Molecular Design · 161
Novel PPAR‐gamma Agonists Identified from a Natural Product Library: A Virtual Screening, Induced‐Fit Docking and Biological Assay Study
2007 · Noeris K. Salam, Tom H‐W. Huang, et al. · Chemical Biology & Drug Design · 141
Contribution of Explicit Solvent Effects to the Binding Affinity of Small‐Molecule Inhibitors in Blood Coagulation Factor Serine Proteases
2011 · Robert Abel, Noeris K. Salam, et al. · ChemMedChem · 126
Structure-based approach to the prediction of disulfide bonds in proteins
2014 · Noeris K. Salam, Matvey Adzhigirey, et al. · Protein Engineering Design and Selection · 110
7-Hydroxy-benzopyran-4-one Derivatives: A Novel Pharmacophore of Peroxisome Proliferator-Activated Receptor α and -γ (PPARα and γ) Dual Agonists
2009 · Azadeh Matin, Navnath Gavande, et al. · Journal of Medicinal Chemistry · 93
A novel LXR-α activator identified from the natural product Gynostemma pentaphyllum
2005 · Tom Hsun-Wei Huang, Valentina Razmovski-Naumovski, et al. · Biochemical Pharmacology · 69
Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-γ-dependent gene transcription in human retinal pigment epithelial cells: Possible implications for diabetic retinopathy treatment
2011 · M.K. Song, N.K. Salam, et al. · Biochemical Pharmacology · 62
Novel γ-Aminobutyric Acid ρ 1 Receptor Antagonists; Synthesis, Pharmacological Activity and Structure−Activity Relationships
2008 · Rohan J. Kumar, Mary Chebib, et al. · Journal of Medicinal Chemistry · 39
Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and Pharmacology
2010 · Navnath Gavande, Izumi Yamamoto, et al. · ACS Medicinal Chemistry Letters · 34
On the Value of Homology Models for Virtual Screening: Discovering hCXCR3 Antagonists by Pharmacophore-Based and Structure-Based Approaches
2012 · Dane Huang, Qiong Gu, et al. · Journal of Chemical Information and Modeling · 28
Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site
2012 · Alexandra Manos-Turvey, Katie M. Cergol, et al. · Organic & Biomolecular Chemistry · 23
Class I β-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions
2008 · Tracy Y.E. Liaw, Noeris K. Salam, et al. · Molecular Cancer Therapeutics · 18
High resolution crystal structures of human kynurenine aminotransferase‐I bound to PLP cofactor, and in complex with aminooxyacetate
2017 · Naveed A. Nadvi, Noeris K. Salam, et al. · Protein Science · 17
T-Cell Antigen Receptor-alpha Chain Transmembrane Peptides: Correlation between Structure and Function
2006 · Marina Ali, Noeris K. Salam, et al. · International Journal of Peptide Research and Therapeutics · 17
A benchmark server using high resolution protein structure data, and benchmark results for membrane helix predictions
2013 · Emma M Rath, Dominique Tessier, et al. · BMC Bioinformatics · 10
PDF
Polyamide-Scorpion Cyclam Lexitropsins Selectively Bind AT-Rich DNA Independently of the Nature of the Coordinated Metal
2011 · Anthony T. S. Lo, Noeris K. Salam, et al. · PLoS ONE · 10
PDF
Generation of structure-based pharmacophores using energetic analysis – application on fragment docking
2011 · Kathryn Loving, Noeris Salam, et al. · Journal of Cheminformatics · 3
PDF
Data from Class I β-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions
2023 · Tracy Y.E. Liaw, Noeris K. Salam, et al.
Supplementary Fig. S1 legend from Class I β-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions
2023 · Tracy Y.E. Liaw, Noeris K. Salam, et al.
Data from Class I β-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions
2023 · Tracy Y.E. Liaw, Noeris K. Salam, et al.
Supplementary Fig. S1 from Class I β-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions
2023 · Tracy Y.E. Liaw, Noeris K. Salam, et al.
Supplementary Fig. S1 from Class I β-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions
2023 · Tracy Y.E. Liaw, Noeris K. Salam, et al.
PDF
Supplementary Table S1 from Class I β-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions
2023 · Tracy Y.E. Liaw, Noeris K. Salam, et al.
PDF
Works count: 30
Citation count: 1,450
H-index: 16
I10-index: 18
Year
Topic
Type